<DOC>
	<DOCNO>NCT00281541</DOCNO>
	<brief_summary>A study YM155 treatment unresectable stage III metastatic stage IV melanoma .</brief_summary>
	<brief_title>A Study Treatment Unresectable Stage III Metastatic Stage IV Melanoma</brief_title>
	<detailed_description>A phase II , multicenter , open-label study subject unresectable Stage III metastatic ( Stage IV ) Melanoma evaluate efficacy safety YM155</detailed_description>
	<mesh_term>Melanoma</mesh_term>
	<criteria>Histologically cytologically confirm unresectable stage III IV malignant melanoma Life expectancy &gt; 12 week History malignancy last 5 year Major surgery within past 21 day</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2012</verification_date>
	<keyword>Treatment Efficacy</keyword>
	<keyword>Treatment Effectiveness</keyword>
	<keyword>Disease Management</keyword>
	<keyword>Treatment</keyword>
	<keyword>Safety</keyword>
	<keyword>Malignant Melanoma</keyword>
</DOC>